SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0000950116-01-000138
Filing Date
2001-02-01
Accepted
2001-02-01 00:00:00
Documents
2
Period of Report
2001-01-16
Items
Item 7: Financial statements and exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A 0001.txt 8-K/A 2644
2 EXHIBIT 4.1 0002.txt EX-4.1 67261
  Complete submission text file 0000950116-01-000138.txt   71468
Mailing Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO M5J A1
Business Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CANA A1 4163642551
GENEREX BIOTECHNOLOGY CORP (Filer) CIK: 0001059784 (see all company filings)

IRS No.: 820490211 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 000-25169 | Film No.: 1521151
SIC: 2834 Pharmaceutical Preparations